echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The first batch of Chinese medicine ISO standards will release black swan, which is disadvantageous to internationalization

    The first batch of Chinese medicine ISO standards will release black swan, which is disadvantageous to internationalization

    • Last Update: 2013-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    2013-05-21 source: Wang Xiaopin, director of International Cooperation Department of State Administration of traditional Chinese medicine of Xinhuanet, said at the 2013 Forum on innovation and development of traditional Chinese medicine industry that "the first batch of ISO standards for traditional Chinese medicine is expected to be published in 2013", which is helpful to overcome international technical barriers and improve the international competitiveness of traditional Chinese medicine products It is suggested to strengthen the supervision of traditional Chinese medicine industry and avoid the influence of "black swan" event on the image of Chinese treasures in the world The overseas radiation of traditional Chinese medicine is increasing day by day The reporter learned on the "2013 Forum on innovation and development of traditional Chinese medicine industry" hosted by China Association of traditional Chinese medicine on August 18 that as of 2012, 119 countries had formulated national policies on traditional medicine, 69 countries had herbal medicine management policies, compared with 65 and 25 in 1999 In addition, 103 countries have made it clear that acupuncture can be used for diagnosis and treatment, 29 countries have regulations on acupuncture management, and 18 countries have incorporated acupuncture into medical insurance At present, traditional Chinese medicine has spread to 168 countries and regions, and become an important choice of medical and health care means in various countries Outside China, there are about 300000 practitioners of all kinds of traditional Chinese medicine and more than 80000 institutions of traditional Chinese medicine (including acupuncture) in the world The world TCM service market is valued at US $50 billion per year Wang Xiaopin analyzed these data and pointed out that the development potential of internationalization of traditional Chinese medicine is huge On the one hand, it is due to the lack of modern medical resources in developing countries On the other hand, due to the growing demand of patients, the limitations of modern medicine are increasingly apparent In addition, traditional medicine has a greater development in the contemporary era Therefore, more and more developed countries also take traditional Chinese medicine as an important supplement to western medicine More importantly, the internationalization of traditional Chinese medicine cannot be separated from the external environment of bilateral cooperation China has signed 97 intergovernmental agreements with 77 countries, and 60 special agreements with the United States, France, Russia, Australia, Mexico and other countries The market enthusiasm is less than the first batch of ISO standards for traditional Chinese medicine of "three mountains" Although the radiation of traditional Chinese medicine abroad is increasing, the three key problems of different cultural background, legal system and sales mode still plague the "going out" of enterprises Liu Zhanglin, vice president of China Chamber of Commerce for the import and export of medical and health care products, said that in the first quarter of this year, the import and export of traditional Chinese medicine products increased by about 20% year-on-year, among which the export markets of traditional Chinese medicine, Chinese herbal pieces, etc are all on the rise Shenzhen heshuntang Pharmaceutical Co., Ltd is a chain of private medical institutions, which is characterized by the implementation of "3 + 1" TCM services in the form of "medicine, medicine, store + factory" Wang Ying, the manager in charge of the company's export business, told reporters that the company's output is sufficient at present After fully supplying the domestic market, the company has been involved in overseas business since 2013 In addition, as a "2012 TCM internationalization promotion enterprise", Lanzhou foci has taken another step in its internationalization Not long ago, Lanzhou fotz and Stockholm University of Sweden jointly established the research center of natural plant medicine and health products of China and Switzerland, which is committed to the establishment of quality evaluation system of traditional Chinese medicine and the integration with international quality standards Although the export enthusiasm of enterprises remains unchanged, overseas cities are not easy to attack Vice president Liu Zhanglin pointed out that enterprises still face three key problems in "going out", one is culture, the other is laws and regulations, and the third is marketing For example, the EU traditional botanical medicine (herbal medicine) registration procedure directive stipulates that from April 30, 2004 to April 2011, traditional botanical medicine that has already been listed and sold in EU member states can continue to be sold, and then it must be registered according to the procedures specified in the Directive before being listed and sold According to the regulations of the European Union, the registration cost of a single Chinese patent medicine is about 1 million yuan, while a traditional Chinese medicine enterprise generally has multiple varieties, plus the handling fees and hardware investment such as the standard certification of drug production quality management, it will be a large cost Even if it is successfully registered to enter the market, the sales channels and models of different countries are not the same, so it is not allowed to copy them at will With the increasingly frequent international trade activities of traditional Chinese medicine, international standardization of traditional Chinese medicine has become an effective way to overcome international technical barriers and promote the international competitiveness of traditional Chinese medicine products Wang Xiaopin said at the meeting that the Technical Committee for standardization of traditional Chinese medicine (hereinafter referred to as ISO / tc249) of the international organization for standardization has developed 32 member countries, 2 international standard proposals have entered the draft stage of the committee, 11 projects have been recognized by all members, and the first batch of ISO standards for traditional Chinese medicine is expected to be published in 2013 Before the event of "black swan" was further improved in quality evaluation and monitoring, media reports on "betel nut, one of the main raw materials of Chinese patent medicine Simotang, was identified as carcinogen by the World Health Organization" attracted great attention of the society According to the feedback from the symposium organized by the industry recently, there are some differences between medicinal areca and edible areca The former is made from the processed kernel of areca, which is processed by the processing, extraction and impurity removal The latter is made from fruit and shell of areca It can be chewed by mouth in a long time after being soaked in lime water, which may increase the incidence rate of oral cancer According to observation, there are many black swan events in the field of traditional Chinese medicine recently For example, Guangdong baoshantang Pharmaceutical Co., Ltd and Guangxi Yingkang Pharmaceutical Co., Ltd were exposed by the media as suspected of illegally using sulfur to fumigate shanyinhua and its branches and leaves to produce drugs In addition, the Department of health of the Hong Kong Special Administrative Region government said on May 7 that the mercury content in the sample of Tongrentang jianti wubu pill was about 5 times of the upper limit standard, so it was ordered to recover It is understood that Chinese herbal medicine from the hands of farmers to purchasers, and then to production enterprises, through a number of links Driven by interests, illegal means such as sulfur fumigation are likely to be used However, when problems are found in sampling inspection, it is difficult to determine which step the problem comes from In addition, "chlorogenic acid" can be detected in honeysuckle, honeysuckle, branches, leaves and flowers, but in turn, this "qualitative test" can not identify which specific part of honeysuckle is used as medicine The industry believes that the "black swan" event will not only make the traditional Chinese medicine industry encounter quality and integrity crisis, but also restrict the internationalization of traditional Chinese medicine It has become an important topic for the development of Chinese traditional medicine industry to improve the research on the quality evaluation system of traditional Chinese medicine, which includes the applicability of new technologies and methods in the process of quality control of traditional Chinese medicine and the improvement of detection standards, the construction of quality evaluation model for the safety and effectiveness of traditional Chinese medicine characteristics, the monitoring of toxic substances of traditional Chinese medicine, "spectrum" and "effect" Research and new ideas, new methods, definition and research of toxic substances, etc Huang Luqi, vice president of the Chinese Academy of traditional Chinese medicine, told reporters that the fourth national survey of traditional Chinese medicine resources is under way The survey monitoring content includes changes in the flow of raw materials, price changes, quality and supply and demand early warning The survey is helpful to explore solutions to the problems restricting the development of the industry, and to promote the establishment and sustainable development of the management mechanism of traditional Chinese medicine resources In addition, for many pharmaceutical enterprises that swim to the "blue ocean" of the big health industry and are involved in the field of health products and food, experts suggest that only by doing well in product quality can they occupy a place in the world and then seize the right to speak It is worth mentioning that the State Food and drug administration has decided to carry out nationwide special actions to combat the "four non" health food from the beginning of May to the end of September in response to such outstanding problems as illegal production, illegal operation, illegal addition and illegal publicity of health food  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.